Aflibercept 2 mg (Eylea, Bayer AG) injections were administered using a prefilled syringe (PFS), following the manufacturer’s indications, with a 30-gauge needle and injecting 0.05 mL of medication (2 ...

The Seoul Central District Court ruled against Regeneron, which had sought to block Samsung Bioepis from producing and selling a biosimilar referencing the US firm’s Eylea, a blockbuster medicine used ...

Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.

The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL ...

Bayer earns license revenues from JNJ for Xarelto sales in the United States. Sales of the ophthalmology drug, Eylea, increased 4.7% to €815 million, driven by higher volumes. The launch of ...

Biotech company Regeneron (NASDAQ:REGN) in Q1 CY2025, with sales falling 3.7% year on year to $3.03 billion. Its non-GAAP ...

Even as Roche makes a major investment pledge across its U.S. business, the Swiss pharmaceutical giant isn’t neglecting its chief markets in Asia. Roche is investing roughly 2.04 billion Chinese ...

Fresh off earning FDA approval for a prefilled syringe version of Vyvgart Hytrulo for at-home administration, argenx is building buzz with a new direct-to-consumer campaign. The “Treatment MY ...

It does not necessarily reflect the view of The Herald. WEAPONS, syringes, mobile phones and illicit drugs such as heroin and cocaine are among the contraband seized from HMP Greenock in the last four ...

In a landmark achievement for Nigeria and the broader West and Central African region, Afrimedical Manufacturing and Supplies Limited has made history by becoming the first syringe manufacturer in ...

DAKAR, May 8 (Reuters) - Sierra Leone accounted for half of Africa's confirmed mpox cases this week, the continent's main health body said on Thursday, adding that the West African country was ...

Alkeus Pharmaceuticals reveals promising Phase 2 SAGA study results, showing gildeuretinol slows vision decline in geographic atrophy linked to AMD. Seemi Khan, MD, MPH, MBA, Chief Medical Officer of ...